共 50 条
- [46] Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38 [J]. BMC CANCER, 2017, 17
- [49] GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer [J]. FRONTIERS IN ONCOLOGY, 2021, 10